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ery systems were taken from a recent meta-analysis. Published
UK costs for 2003, health care resource utilization and clinical
data, and recommended discount rates were used (3.5% per
annum on costs and outcomes). A lifetime horizon and third
party payer perspective was taken. Only direct costs were 
considered. Extensive sensitivity analyses were performed.
RESULTS: Treatment with CSII was associated with an improve-
ment in life expectancy (LE) of 0.72 years compared to MDI
(mean LE 17.37 ± 6.81 versus 16.66 ± 6.62 years). Quality
adjusted life expectancy (QALE) improved by 0.59 years with
CSII versus MDI (mean QALE 10.23 ± 3.89 versus 9.64 ± 3.69
years). Mean direct lifetime costs were £19,413 more expensive
with CSII treatment versus MDI (£81,115 versus £57,015). This
produced an incremental cost effectiveness ratio of £32,753 per
quality adjust life year saved with CSII compared to MDI. The
main difference between the two arms was in medication costs.
Sensitivity analysis showed the results were robust under a range
of assumptions. CONCLUSIONS: Improvements in glycemic
control associated with CSII versus MDI lead to improvements
in LE and QALE due reduced incidence of diabetes-related com-
plications. CSII is cost effective compared to MDI according to
accepted international thresholds.
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OBJECTIVE: Inguinal hernia repair is a common surgical pro-
cedure. Available evidence suggests that there are advantages and
disadvantages to open and laparoscopic repair. The value that
patients attach to the proﬁle of outcomes is uncertain. The objec-
tive is to elicit patients’ values for the proﬁle of outcomes for
each surgical technique. METHODS: A postal discrete choice
survey was developed containing 7 attributes with 3 levels each,
identiﬁed from the literature, expert opinion and a pilot study.
A fractional factorial design reduced the number of scenarios to
18, using SPEED. The scenarios were systematically paired into
9 binary choices to derive an efﬁcient design (orthogonality, level
balance, utility balance and minimal overlap). Respondents were
asked to choose operation A or B in each pair-wise choice and
indicate the strength of their preference. Dominance and consis-
tency tests, and a ranking exercise were also included. Results
were analysed in STATA using a random effects probit model.
The study sample was 50 post-operative patients (25 laparo-
scopic, 25 open) and 50 patients waiting for an inguinal hernia
repair at one hospital. RESULTS: In total, 63% of patients
returned the questionnaire, (18 post-laparoscopic, 10 post-open
and 35 waiting). The mean age of respondents was 53 years
(range: 25 :87), 58% were retired. Initial analysis of complete
responses, based on the sign and signiﬁcance of the regression
coefﬁcients, indicated patients prefer operations with: 1 over-
night stay (b = 0.446) to those with 0 or 2+ nights; least risk of
operative-complications (b = -0.195); longer return to usual
activities (b = 0.049); least post-operative pain (b = -0.042);
lowest chance of recurrence (b = -0.033); complications after the
operation (b = 0.031); and, least long-term pain (b = -0.009).
Overall the signs on the coefﬁcients were consistent with a priori
expectations. All attributes were statistically signiﬁcant (p <
0.01). CONCLUSION: Patients value those attributes describ-
ing immediate care/outcome more than those that affect long-
term outcome. 
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OBJECTIVES: EQ-5D deﬁnes health in terms of 5 dimensions
each divided into 3 levels, forming a classiﬁcation of 245 states.
The ﬁrst level within each dimension corresponds to “no
problem” and it has been suggested that the classiﬁcation lacks
scope for sensitivity. A 5-level descriptive classiﬁcation offers
advantages with smaller step sizes than is presently the case,
leading to reduced ceiling effects. This paper reports on a study
that compares self-rated health status in a patient survey using
a modiﬁed 5-level descriptive classiﬁcation alongside the con-
ventional 3-level EQ-5D. METHODS: EQ-5D was modiﬁed by
inserting an intermediate level between the existing levels 1&2
and 2&3. No text labels were provided for these levels 2 and 4
of the modiﬁed version. A questionnaire containing both 3-level
and 5-level responses systems was constructed. The order of pre-
sentation was varied with 50% presenting the standard EQ-5D
format ﬁrst; in the remainder the 5-level version was presented
ﬁrst. Questionnaires were mailed out to over 2000 individuals
selected from the national electoral register. RESULTS: Data
from 950 respondents were available for analysis (n = 478 for
3-5 version and 472 for the 5-3 version respectively). 64% of
respondents were indifferent when asked which version they pre-
ferred. Of the remainder 65% preferred the 5-level version.
Response errors were deﬁned as a difference in response of more
than 1 level between the 2 versions and these were generally less
than 1%. There was a smaller ceiling effect and only 39% of
respondents reported no problems on the 5-level version. The
corresponding rate for the 3-level version was 50%. CONCLU-
SIONS: A 5-level response system for EQ-5D is feasible. The
revised version produced a wider distribution of reported prob-
lems with less compacting towards level 1. Backwards com-
patability ensures that existing valuation sets can be used with
both 3- and 5-level systems.
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OBJECTIVES: The Barthel Index (BI) is a validated activities of
daily living (ADL) scale covering bowel and bladder functioning,
grooming, toileting, feeding, transfers, mobility, dressing, stairs,
and bathing. Scores range from 0–100 (0 = total dependence,
100 = complete independence). Mathematically, the BI allows for
5,146 possible proﬁles; however, many do not occur clinically
due to hierarchical conservation of function. Published informa-
tion on clinical representation of BI proﬁles and diversity within
scores is scarce. We explored those issues and their clinical and
economic implications. METHODS: A BI proﬁle was deﬁned as
the score set for the ten ADL items. Complete BI proﬁles from
246 stroke inpatients were entered into a database and seg-
mented by score. Data were validated against published ﬁndings.
For each score, the number of unique proﬁles and their fre-
quencies were calculated. The clinical and economic implications
of differences in proﬁles at the same score were assessed.
RESULTS: In total, 697 complete BI proﬁles were obtained from
patient data, of which 246 were unique. Excepting the scoring
extremes, the number of unique proﬁles at each BI score ranged
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from 4–23 with the greatest variety in the mid-range. A small
number of proﬁles usually accounted for the majority that
occurred at each score. Differences in functioning were observed
across 2–5 ADLs at scores of 5–15 and 90–95, and across 7–9
ADLs at scores of 20–85. CONCLUSIONS: Only a fraction
(5%) of possible BI proﬁles occur clinically in stroke. Patients
with the same BI scores may vary in ADL functioning and require
different levels of clinical management. Depending on how ADLs
are valued, preferences for disability states within scores may
vary. In clinical trials, scores alone may not capture treatment
effects that are important to patients. Properly adapted, a 
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OBJECTIVES: To examine the relationship between health
insurance type and prescribed drug costs for orthopedic outpa-
tients of a regional hospital in southern Thailand. METHODS:
Electronic data for 3117 prescriptions for osteoarthritis (OA)
and rheumatoid arthritis (RA) new patients, whose age was 40
years or older and obtained their outpatient prescriptions from
October 1, 2001 to September 30, 2002, were analyzed. Descrip-
tive and linear regression analyses were used to analyze overall
and subgroup (OA and RA) data. RESULTS: Results showed
94.6% of the patients had osteoarthritis. They were divided into
three groups of health insurance type, which were Civil Servant
Medical Beneﬁt Scheme (CSMBS), Universal Coverage Scheme
(UC), and Social Security Scheme (SSS). While the SSS and UC
schemes paid by capitation basis, the CSMBS did by fee-for-
service basis. The CSMBS and SSS patients received higher
average cost per prescription and average cost per day than did
the UC patients. The RA patients obtained more expensive drugs
than did the OA patients. For OA patients, the CSMBS patients
had the lowest number of drugs per prescription. However, the
average cost per prescription and average cost per day of the
CSMBS and SSS patients were signiﬁcantly higher than those of
the UC patients. For RA patients, the average cost per prescrip-
tion and average cost per day of the UC patients were less than
those of the CSMBS and SSS patients, while their numbers of
drugs per prescription were slightly different. The regression
analysis for all patients and each subgroup showed signiﬁcant
relationship between the patients’ health insurance type and
average cost per prescription and average cost per day. CON-
CLUSIONS: A signiﬁcant relationship between the health insur-
ance type and prescription drug costs was found. The UC
patients tended to receive less expensive drugs than did the
others.
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OBJECTIVES: To promote rational drug use, governments may
apply various instruments to aid health care professionals in clin-
ical decision-making. Guidelines are a common approach, but
their impact on clinical practice is often limited. Therefore the
Dutch government sometimes applies a stronger instrument: con-
ditional reimbursement enforced by law, applied to drug groups
listed on the so-called “Annex 2”. We assessed process and 
outcomes of this instrument. METHODS: We quantitatively
explored the effects of conditional reimbursement on drug use
and costs for 33 Annex 2-drugs using the national GIP-database
that administers funding decisions for people in insurance
schemes. The qualitative process evaluation used document
analyses, interviews (N = 70), and case studies (N = 6) to map
perceptions of patients, physicians, pharmacists, insurers, man-
ufacturers, and policy makers to attain insights into the perfor-
mance of Annex 2. In focus groups we triangulated ﬁndings and
identiﬁed improvements. RESULTS: The quantitative analysis
showed that effects of conditional reimbursement varied with
type of conditions and clinical setting. People responsible for
implementation complained about administrative burden and
lack of means to monitor if conditions for reimbursement were
met (e.g. statins). An additional problem is that Annex 2 condi-
tions lag behind evolving clinical knowledge (e.g. clopidogrel).
The way in which conditions were operationalised appeared
crucial for their implementation. When stakeholders had been
actively involved in their operationalisation (e.g. TNF-b-block-
ers) implementation was successful, lack of consensus on the
conditions was detrimental to effectiveness of Annex 2 policy.
CONCLUSIONS: Overall, Annex 2 is considered a necessary
instrument, although there are conditions to be met for a more
effective functioning in the near future. There is a demand for
more dynamic and pro-active communication strategy by the dif-
ferent Annex 2-actors to increase awareness of the existing policy
and to narrow the gap between the clinical practice and policy
regarding registration and reimbursement of drugs.
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There is a global need for education in the ﬁeld of pharma-
coeconomics (PE). One is provided by Colleges of Pharmacy
(COP’s). Several surveys were conducted during the 1990’s to
determine the extent of pharmacoeconomic education at US-
based COP’s. One survey found that by 1999, 90% of US COP’s
provided PE education. On the other hand, only one study, con-
ducted in 1997, was found that surveyed Non-US COP’s. A total
of 112 Non-US COP’s in 44 countries were surveyed via e-mail;
41 COP’s from 25 countries responded. Seventeen COP’s from
13 countries reported providing PE education. OBJECTIVE: The
objective of this study was to perform a follow-up study for Non-
US COP’s. METHODS: During January—May, 2004, surveys
were sent to 291 Non-US COP’s in 42 countries via e-mail using
information from the World List of Pharmacy Schools (WLPS).
Follow-up e-mails were sent to non-respondents and to respon-
dents when clariﬁcations of their responses were needed.
RESULTS: A total of 89 COP’s from 42 countries provided
usable responses. A total of 46 COP’s from 28 countries indi-
cated that they provided PE education. Of these 46 COP’s, nine
provided education at the professional level only, 15 at the grad-
uate level only and 22 at both levels. The median number of stu-
dents enrolled at the professional level was 100, and 15 at the
graduate level. The median number of class contact hours for PE
education was 12 for professional students and 15 for graduate
students. CONCLUSIONS: Fifty-one percent (51%)of respon-
dents provided PE education compared to 41% from the 1997
survey. The majority of Non-US COP’s that offered PE educa-
